EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for SRRK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Krystal Biotech, Inc. 1.833
Stoke Therapeutics, Inc. -0.7929
Biogen, Inc. 2.153
Apellis Pharmaceuticals, Inc. 0.142
Zymeworks, Inc. -0.592

EPS Diluted (Quarterly) Related Metrics